Cargando…
Time dependence of biomarkers: non-proportional effects of immunohistochemical panels predicting relapse risk in early breast cancer
BACKGROUND: We investigated the impact of follow-up duration to determine whether two immunohistochemical prognostic panels, IHC4 and Mammostrat, provide information on the risk of early or late distant recurrence using the Edinburgh Breast Conservation Series and the Tamoxifen vs Exemestane Adjuvan...
Autores principales: | Stephen, J, Murray, G, Cameron, D A, Thomas, J, Kunkler, I H, Jack, W, Kerr, G R, Piper, T, Brookes, C L, Rea, D W, van de Velde, C J H, Hasenburg, A, Markopoulos, C, Dirix, L, Seynaeve, C, Bartlett, J M S |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4264442/ https://www.ncbi.nlm.nih.gov/pubmed/25314051 http://dx.doi.org/10.1038/bjc.2014.530 |
Ejemplares similares
-
Do type 1 receptor tyrosine kinases inform treatment choice? A prospectively planned analysis of the TEAM trial
por: Bartlett, J M S, et al.
Publicado: (2013) -
Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
por: Bayani, Jane, et al.
Publicado: (2017) -
Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study
por: Bartlett, John M. S., et al.
Publicado: (2021) -
Pathway-based subnetworks enable cross-disease biomarker discovery
por: Haider, Syed, et al.
Publicado: (2018) -
Changing pattern of the detection of locoregional relapse in breast cancer: the Edinburgh experience
por: Montgomery, D A, et al.
Publicado: (2007)